Application 050756
- Type
- NDA
- Sponsor
- BAUSCH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BENZACLIN | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | GEL;TOPICAL | 5%;EQ 1% BASE | Yes | Yes |
| 002 | BENZACLIN | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | GEL;TOPICAL | 5%;EQ 1% BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0187-5190 | Benzaclin | Clindamycin phosphate and benzoyl peroxide | Valeant Pharmaceuticals North America LLC | NDA | Current |
| 0187-5190 | Benzaclin | Clindamycin phosphate and benzoyl peroxide | Bausch Health US LLC | NDA | Current |
| 0187-5190 | Benzaclin | Clindamycin phosphate and benzoyl peroxide | Bausch Health US LLC | NDA | Current |
| 0187-5190 | Benzaclin | Clindamycin phosphate and benzoyl peroxide | Bausch Health Americas, Inc. | NDA | Current |
| 68682-190 | Clindamycin phosphate and benzoyl peroxide | Clindamycin phosphate and benzoyl peroxide | Oceanside Pharmaceuticals | NDA | Current |
| 68682-190 | Clindamycin phosphate and benzoyl peroxide | Clindamycin phosphate and benzoyl peroxide | Oceanside Pharmaceuticals | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8205 | SUPPL | 2011-03-08 |
| 18187 | SUPPL | 2011-03-07 |
| 39268 | SUPPL | 2010-06-24 |
| 8204 | SUPPL | 2010-06-18 |
| 39267 | SUPPL | 2009-06-22 |
| 8203 | SUPPL | 2009-06-17 |
| 30461 | SUPPL | 2007-06-04 |
| 18185 | SUPPL | 2007-05-29 |
| 30462 | SUPPL | 2007-05-01 |
| 18186 | SUPPL | 2007-04-25 |
| 30460 | SUPPL | 2005-05-02 |
| 18184 | SUPPL | 2005-05-02 |
| 39266 | SUPPL | 2002-08-09 |
| 8202 | SUPPL | 2002-08-09 |
| 42718 | ORIG | 2000-12-21 |
| 18183 | ORIG | 2000-12-21 |
| 8201 | ORIG | 2000-12-21 |